Page last updated: 2024-11-04

rolipram and Bacteremia

rolipram has been researched along with Bacteremia in 1 studies

Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.

Research Excerpts

ExcerptRelevanceReference
"Bacteremia-induced sepsis is a leading cause of mortality in intensive care units."1.62Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice. ( Alalaiwe, A; Dai, YS; Fang, JY; Liao, CC; Liu, FC; Yang, SC; Yu, HP, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liao, CC1
Yu, HP1
Yang, SC1
Alalaiwe, A1
Dai, YS1
Liu, FC1
Fang, JY1

Other Studies

1 other study available for rolipram and Bacteremia

ArticleYear
Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice.
    Journal of nanobiotechnology, 2021, Feb-15, Volume: 19, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteremia; Ciprofloxacin; Disease Models,

2021